Interaction of A3 adenosine receptor ligands with the human multidrug transporter ABCG2
- 10 January 2022
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 231, 114103
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
- National Institutes of Health
- National Cancer Institute (ZIABC010030)
- National Institute of Diabetes and Digestive and Kidney Diseases (ZIADK31117)
This publication has 40 references indexed in Scilit:
- Extended N6 substitution of rigid C2-arylethynyl nucleosides for exploring the role of extracellular loops in ligand recognition at the A3 adenosine receptorBioorganic & Medicinal Chemistry Letters, 2014
- Truncated Nucleosides as A3 Adenosine Receptor Ligands: Combined 2-Arylethynyl and Bicyclohexane SubstitutionsACS Medicinal Chemistry Letters, 2012
- Use of Baculovirus BacMam Vectors for Expression of ABC Drug Transporters in Mammalian CellsDrug Metabolism and Disposition, 2012
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- ABCG2: structure, function and role in drug responseExpert Opinion on Drug Metabolism & Toxicology, 2007
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Correlation between Steady-state ATP Hydrolysis and Vanadate-induced ADP Trapping in Human P-glycoproteinJournal of Biological Chemistry, 2001
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.Proceedings of the National Academy of Sciences, 1987